A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2019-12-30
Target enrollment:
Participant gender:
Summary
This Phase 2 is a randomized study in advanced Non-Small Cell lung cancer patients to
evaluate safety and efficacy of aerosolized BIO-11006 in conjunction with chemotherapy.